Literature DB >> 16614020

Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation.

A O Rossetti1, S Hurwitz, G Logroscino, E B Bromfield.   

Abstract

BACKGROUND: Identification of outcome-predictive factors could lower risk of under- or over-treatment in status epilepticus (SE). Older age and acute symptomatic aetiology have been shown to predict mortality, but other variables are controversial and level of consciousness has received relatively little attention. The objective of this study was to assess variables predictive of mortality, particularly those available at presentation.
METHODS: The discharge database (1997-2004) of two university hospitals was screened for adult patients with EEG confirmed SE, excluding cerebral anoxia. Outcome at discharge (mortality, return to baseline clinical conditions) was analysed in relation to demographics, clinical features, and aetiology. Aetiologies were also classified based on whether or not they were potentially fatal independently of SE.
RESULTS: Mortality was 15.6% among 96 patients with a first SE episode, 10 of whom also experienced recurrent SE during the study period. Eleven other patients had only recurrent SE. Mortality was 4.8% among these 21 patients with recurrent SE. Return to baseline condition was more frequent after recurrent than incident SE (p=0.02). For the first SE episode, death was associated with potentially fatal aetiology (p=0.01), age>or=65 (p=0.02), and stupor or coma at presentation (p=0.04), but not with gender, history of epilepsy, SE type, or time to treatment>or=1 h.
CONCLUSIONS: At initial evaluation, older age and marked impairment of consciousness are predictive of death. Surviving a first SE episode could lower the mortality and morbidity of subsequent episodes, suggesting that underlying aetiology, rather than SE per se, is the major determinant of outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16614020      PMCID: PMC2117456          DOI: 10.1136/jnnp.2005.080887

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  33 in total

1.  The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists.

Authors:  M Holtkamp; F Masuhr; L Harms; K M Einhäupl; H Meierkord; K Buchheim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

Review 2.  Status epilepticus on the intensive care unit.

Authors:  Matthew C Walker
Journal:  J Neurol       Date:  2003-04       Impact factor: 4.849

Review 3.  The biochemical basis and pathophysiology of status epilepticus.

Authors:  E Lothman
Journal:  Neurology       Date:  1990-05       Impact factor: 9.910

4.  Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1993 Jul-Aug       Impact factor: 5.864

Review 5.  Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus.

Authors: 
Journal:  JAMA       Date:  1993-08-18       Impact factor: 56.272

6.  Propofol treatment of refractory status epilepticus: a study of 31 episodes.

Authors:  Andrea O Rossetti; Marc D Reichhart; Marie-Denise Schaller; Paul-André Despland; Julien Bogousslavsky
Journal:  Epilepsia       Date:  2004-07       Impact factor: 5.864

7.  Nonconvulsive status epilepticus in adults: thirty-two consecutive patients from a general hospital population.

Authors:  T Tomson; U Lindbom; B Y Nilsson
Journal:  Epilepsia       Date:  1992 Sep-Oct       Impact factor: 5.864

8.  Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy.

Authors:  Luca Vignatelli; Caterina Tonon; Roberto D'Alessandro
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864

9.  Assessment of acute morbidity and mortality in nonconvulsive status epilepticus.

Authors:  Bassel F Shneker; Nathan B Fountain
Journal:  Neurology       Date:  2003-10-28       Impact factor: 9.910

Review 10.  Is it status?

Authors:  Richard P Brenner
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

View more
  61 in total

Review 1.  Management of refractory status epilepticus in adults: still more questions than answers.

Authors:  Andrea O Rossetti; Daniel H Lowenstein
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

Review 2.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

3.  Management of status epilepticus in neurological versus medical intensive care unit: does it matter?

Authors:  Panayiotis N Varelas; Jesse Corry; Mohammed Rehman; Tamer Abdelhak; Lonni Schultz; Marianna Spanaki; James Bartscher
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

4.  The epidemiology of status epilepticus in the United States.

Authors:  Bhavpreet S Dham; Krystal Hunter; Fred Rincon
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

5.  Evaluation of STESS, mRSTESS, and EMSE to Predict High Disability and Mortality at Hospital Discharge in Ecuadorian Patients with Status Epilepticus.

Authors:  Dannys Rivero Rodríguez; Claudio Scherle Matamoros; Kimberly Sam; Daniela DiCapua Sacoto; Nelson Maldonado Samaniego; Yanelis Pernas
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

Review 6.  Recent developments in the diagnosis and treatment of status epilepticus.

Authors:  Megan Selvitelli; Frank W Drislane
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

7.  Status epilepticus: Using antioxidant agents as alternative therapies.

Authors:  Liliana Carmona-Aparicio; Cecilia Zavala-Tecuapetla; María Eva González-Trujano; Aristides Iii Sampieri; Hortencia Montesinos-Correa; Leticia Granados-Rojas; Esaú Floriano-Sánchez; Elvia Coballase-Urrutía; Noemí Cárdenas-Rodríguez
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

8.  Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts.

Authors:  Luca Vignatelli; Rita Rinaldi; Elisa Baldin; Paolo Tinuper; Roberto Michelucci; Massimo Galeotti; Piero de Carolis; Roberto D'Alessandro
Journal:  J Neurol       Date:  2008-01-23       Impact factor: 4.849

9.  Intravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomes.

Authors:  Utku Uysal; Mark Quigg; Brennen Bittel; Nancy Hammond; Theresa I Shireman
Journal:  Epilepsy Res       Date:  2015-07-26       Impact factor: 3.045

10.  Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy.

Authors:  Andrea O Rossetti; Giancarlo Logroscino; Tracey A Milligan; Costas Michaelides; Christiane Ruffieux; Edward B Bromfield
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.